Computational drug repurposing for viral infectious diseases: a case study on monkeypox

S Saha, P Chatterjee, M Nasipuri, S Basu… - Briefings in …, 2024 - academic.oup.com
The traditional method of drug reuse or repurposing has significantly contributed to the
identification of new antiviral compounds and therapeutic targets, enabling rapid response …

Differential co-expression network analysis reveals key hub-high traffic genes as potential therapeutic targets for COVID-19 pandemic

A Hasankhani, A Bahrami, N Sheybani, B Aria… - Frontiers in …, 2021 - frontiersin.org
Background The recent emergence of COVID-19, rapid worldwide spread, and incomplete
knowledge of molecular mechanisms underlying SARS-CoV-2 infection have limited …

Identification of essential genes associated with SARS-CoV-2 infection as potential drug target candidates with machine learning algorithms

G Taheri, M Habibi - Scientific Reports, 2023 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requires the fast discovery
of effective treatments to fight this worldwide concern. Several genes associated with the …

Integrated network analysis reveals new genes suggesting COVID-19 chronic effects and treatment

A Pavel, G Del Giudice, A Federico… - Briefings in …, 2021 - academic.oup.com
The COVID-19 disease led to an unprecedented health emergency, still ongoing worldwide.
Given the lack of a vaccine or a clear therapeutic strategy to counteract the infection as well …

Deciphering the complete human-monkeypox virus interactome: Identifying immune responses and potential drug targets

R Kataria, S Kaur, R Kaundal - Frontiers in Immunology, 2023 - frontiersin.org
Monkeypox virus (MPXV) is a dsDNA virus, belonging to Poxviridae family. The outbreak of
monkeypox disease in humans is critical in European and Western countries, owing to its …

Computationally prioritized drugs inhibit SARS-CoV-2 infection and syncytia formation

A Serra, M Fratello, A Federico, R Ojha… - Briefings in …, 2022 - academic.oup.com
The pharmacological arsenal against the COVID-19 pandemic is largely based on generic
anti-inflammatory strategies or poorly scalable solutions. Moreover, as the ongoing …

Computational approach to combat COVID-19 infection: emerging tools for accelerating drug research

BM Sahoo, SK Bhattamisra, S Das… - Current Drug …, 2022 - ingentaconnect.com
Background: The process of drug discovery and development is expensive, complex,
timeconsuming, and risky. There are different techniques involved in the process of drug …

ML-DTD: machine learning-based drug target discovery for the potential treatment of COVID-19

S Saha, P Chatterjee, AK Halder, M Nasipuri, S Basu… - Vaccines, 2022 - mdpi.com
Recent research has highlighted that a large section of druggable protein targets in the
Human interactome remains unexplored for various diseases. It might lead to the drug …

Assessment of GO-based protein interaction affinities in the large-scale human–coronavirus family interactome

SS Bandyopadhyay, AK Halder, S Saha, P Chatterjee… - Vaccines, 2023 - mdpi.com
SARS-CoV-2 is a novel coronavirus that replicates itself via interacting with the host
proteins. As a result, identifying virus and host protein-protein interactions could help …

TiO2/Arabic Gum for Degradation of Pollutants in Water

A Lopes, FP Araújo, D Damasceno, LMC Honório… - Sustainability, 2023 - mdpi.com
Emerging contaminants and pollution are environmental problems threatening public health.
Antibiotic ciprofloxacin and methylene blue dye are pollutants frequently detected in water …